Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
23.21
+1.29 (5.89%)
Aug 13, 2025, 4:00 PM - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $335.99 million as of August 14, 2025. Its market cap has increased by 69.05% in one year.
Market Cap
335.99M
Enterprise Value
261.42M
1-Year Change
69.05%
Ranking
Category
Stock Price
$23.21
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $335.99M, an increase of 69.49%. That is a compound annual growth rate of 54.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 317.31M | 42.34% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |